Lorne Tyrrell is one of six "medical heroes" joining the ranks of 82 Canadian Medical Hall of Fame laureates April 28 in London, Ont. He will be inducted in two categories: Builder and Excellence in Health Research.
Tyrrell led the University of Alberta's medical school for 10 years, developed the antiviral therapy for hepatitis B now being used around the globe and he was the driving force behind the development of the Li Ka Shing Institute of Virology-a facility that has vaulted the Faculty of Medicine & Dentistry and the U of A to prominence as a world centre of excellence in viral research. He also holds the CIHR/GSK Chair in Virology in the Department of Medical Microbiology and Immunology at the University of Alberta.